These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

113 related articles for article (PubMed ID: 19286183)

  • 21. Social marketing program sales.
    Soc Mark Forum; 1984; 1(4):6-7. PubMed ID: 12266334
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Improving manual vacuum aspiration service delivery, introducing misoprostol for cases of incomplete abortion, and strengthening postabortion contraception in Bangladesh.
    Begum F; Zaidi S; Fatima P; Shamsuddin L; Anowar-ul-Azim AK; Begum RA
    Int J Gynaecol Obstet; 2014 Jul; 126 Suppl 1():S31-5. PubMed ID: 24792403
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Status and expertise of off-label use of misoprostol in obstetrics and gynecology in France: study by CNGOF (short text)].
    Marret H; Simon E; Beucher G; Dreyfus M; Gaudineau A; Vayssière C; Lesavre M; Pluchon M; Winer N; Fernandez H; Aubert J; Bejan-Angoulvant T; Jonville-Bera AP; Clouqueur E; Houfflin-Debarge V; Garrigue A; Pierre F;
    J Gynecol Obstet Biol Reprod (Paris); 2014 Feb; 43(2):107-13. PubMed ID: 24438770
    [No Abstract]   [Full Text] [Related]  

  • 24. Misoprostol: a quarter century of use, abuse, and creative misuse.
    Chong YS; Su LL; Arulkumaran S
    Obstet Gynecol Surv; 2004 Feb; 59(2):128-40. PubMed ID: 14752301
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Physicians' approaches to post-abortion care in Manila, Philippines.
    Cansino C; Melgar JL; Burke A
    Int J Gynaecol Obstet; 2010 Jun; 109(3):216-8. PubMed ID: 20176351
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The Brazilian experience with Cytotec.
    Barbosa RM; Arilha M
    Stud Fam Plann; 1993; 24(4):236-40. PubMed ID: 8212093
    [TBL] [Abstract][Full Text] [Related]  

  • 27. New hope: community-based misoprostol use to prevent postpartum haemorrhage.
    Prata N; Passano P; Bell S; Rowen T; Potts M
    Health Policy Plan; 2013 Jul; 28(4):339-46. PubMed ID: 22879523
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Civil Society Organizations and medicines policy change: a case study of registration, procurement, distribution and use of misoprostol in Uganda.
    Atukunda EC; Brhlikova P; Agaba AG; Pollock AM
    Soc Sci Med; 2015 Apr; 130():242-9. PubMed ID: 25728484
    [TBL] [Abstract][Full Text] [Related]  

  • 29. How often and under which circumstances do Mexican pharmacy vendors recommend misoprostol to induce an abortion?
    Lara D; García SG; Wilson KS; Paz F
    Int Perspect Sex Reprod Health; 2011 Jun; 37(2):75-83. PubMed ID: 21757422
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Misoprostol in resource poor countries.
    Bergström S; Aronsson A
    BMJ; 2008 May; 336(7652):1032. PubMed ID: 18467383
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Misoprostol and the politics of abortion in Sri Lanka.
    Kumar R
    Reprod Health Matters; 2012 Dec; 20(40):166-74. PubMed ID: 23245422
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Mifepristone plus vaginal misoprostol vs vaginal misoprostol alone for medical abortion in gestation 63 days or less in Nepalese women: a quasi-randomized controlled trial.
    Chawdhary R; Rana A; Pradhan N
    J Obstet Gynaecol Res; 2009 Feb; 35(1):78-85. PubMed ID: 19215552
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Overview and expert assessment of off-label use of misoprostol in obstetrics and gynaecology: review and report by the Collège national des gynécologues obstétriciens français.
    Marret H; Simon E; Beucher G; Dreyfus M; Gaudineau A; Vayssière C; Lesavre M; Pluchon M; Winer N; Fernandez H; Aubert J; Bejan-Angoulvant T; Jonville-Bera AP; Clouqueur E; Houfflin-Debarge V; Garrigue A; Pierre F;
    Eur J Obstet Gynecol Reprod Biol; 2015 Apr; 187():80-4. PubMed ID: 25701235
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The effect of non-steroidal anti-inflammatory drugs on medical abortion with mifepristone and misoprostol at 13-22 weeks gestation.
    Fiala C; Swahn ML; Stephansson O; Gemzell-Danielsson K
    Hum Reprod; 2005 Nov; 20(11):3072-7. PubMed ID: 16055455
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Contraceptive retail surveys locate problems of acceptance.
    Netw Res Triangle Park N C; 1985; 6(4):6-7. PubMed ID: 12340326
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Clinical uses of misoprostol in obstetrics and gynecology].
    Yu J; Zhang J; Song Y
    Zhonghua Fu Chan Ke Za Zhi; 1998 Jan; 33(1):55-7. PubMed ID: 10682459
    [No Abstract]   [Full Text] [Related]  

  • 37. Introduction of misoprostol for the treatment of incomplete abortion beyond 12 weeks of pregnancy in Benin.
    Adisso S; Hounkpatin BI; Komongui GD; Sambieni O; Perrin RX
    Int J Gynaecol Obstet; 2014 Jul; 126 Suppl 1():S36-9. PubMed ID: 24800660
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Mifepristone and misoprostol in therapeutic abortions].
    Jannet D; Aflak N; Chemla JP; Marpeau L; Milliez J
    J Gynecol Obstet Biol Reprod (Paris); 1996; 25(3):277-82. PubMed ID: 8767226
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Does methotrexate confer a significant advantage over misoprostol alone for early medical abortion? A retrospective analysis of 8678 abortions.
    Aldrich T; Winikoff B
    BJOG; 2007 May; 114(5):555-62. PubMed ID: 17439563
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Misoprostol--a new prostaglandin in obstetrical practice].
    Katsulov A; Todorova Ts
    Akush Ginekol (Sofiia); 1998; 37(2):59-66. PubMed ID: 9859543
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.